Ниже приведен неполный список книг, статей и онлайн-ресурсов, которые могут быть источником дополнительной информации о ряде идей и концепций, изложенных в книге. Это не исчерпывающий список, но он поможет вам начать с новой точки зрения и жить в соответствии с принципами книги. Многие цитаты взяты из исследований, упомянутых или подробно описанных в тексте. Эти материалы также могут стать основой дальнейших исследований. Если вы не увидите ссылку, упомянутую в книге, посетите сайт DrPerlmutter.com, где вы получите доступ к дополнительным исследованиям и обновляемому списку ссылок.
Peterattiamd.com.
Здесь и далее автор говорит об уровнях тех или иных показателей во множественном числе, поскольку концентрация в крови меняется много раз в течение дня и замер в конкретное время не отражает всей картины. Прим. пер.
Centers for Disease Control and Prevention (cdc.gov); American Heart Association (heart.org).
Hidden in Plain Sight // SugarScience, University of California at San Francisco // sugarscience.ucsf.edu/hidden-in-plain-sight/.
Haig A. Uric Acid as a Factor in the Causation of Disease: A Contribution to the Pathology of High Arterial Tension, Headache, Epilepsy, Mental Depression, Paroxysmal Hæmoglobinuria and Anæmia, Bright’s Disease, Diabetes, Gout, Rheumatism, and Other Disorders. London: Franklin Classics, 2018. См. также Haig A. Uric Acid as a Factor in the Causation of Disease – A Contribution to the Pathology of High Blood Pressure, Headache, Epilepsy, Mental Depression, Paroxysmal Hemoglobinuria and Anemia, Bright’s Disease, Gout, Rheumatism and other Disorders // JAMA. 1898. Vol. 31. № 3. P. 139 // doi.org/10.1001/jama.1898.02450030041022.
Fragkou Th., Goula K., Drakoulogkona O. The History of Gout Through Centuries // Nephrology Dialysis Transplantation. 2015. May. Vol. 30. Suppl. 3. Pp. iii377–iii380 // doi.org/10.1093/ndt/gfv186.05.
Oxford English Dictionary, 2nd ed. Oxford, UK: Oxford University Press, 2004.
Nuki G., Simkin P. A. A Concise History of Gout and Hyperuricemia and Their Treatment // Arthritis Research & Therapy. 2006. Vol. 8. Suppl. 1. P. S1 // doi.org/10.1186/ar1906.
Maurer J. Early Gout Is Bad for the Heart: Recent Research Context // Med-Page Today, November 28, 2019 // medpagetoday.com/reading-room/acrr/generalrheumatology/83581. См. также Li Y. et al. Clinical Characteristics of Early-Onset Gout in Outpatient Setting // ACR Open Rheumatology. 2019. Vol. 1. № 7. Pp. 397–402 // doi.org/10.1002/acr2.11057.
Singh J. A. Gout: Will the “King of Diseases” Be the First Rheumatic Disease to Be Cured? // BMC Medicine. 2016. Vol. 14. P. 180 // doi.org/10.1186/s12916-016-0732-1.
George Ch., Minter D. A. Hyperuricemia // StatPearls. Treasure Island, FL: 2021 // ncbi.nlm.nih.gov/books/NBK459218/.
Chen J.-H. et al. Serum Uric Acid Level as an Independent Risk Factor for All-Cause, Cardiovascular, and Ischemic Stroke Mortality: A Chinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol. 61. № 2. Pp. 225–232 // doi.org/10.1002/art.24164. См. также Prado de Oliveira E., Burini R. C. High Plasma Uric Acid Concentration: Causes and Consequences // Diabetology & Metabolic Syndrome. 2012. April. Vol. 4. P. 12 // doi.org/10.1186/1758-5996-4-12.
El Ridi R., Tallima H. Physiological Functions and Pathogenic Potential of Uric Acid: A Review // Journal of Advanced Research. 2017. September. Vol. 8. № 5. Pp. 487–493 // doi.org/10.1016/j.jare.2017.03.003.
El Ridi and Tallima, Physiological Functions and Pathogenic Potential of Uric Acid.
DiNicolantonio J. J., O’Keefe J. H., Lucan S. C. Added Fructose: A Principal Driver of Type 2 Diabetes Mellitus and Its Consequences // Mayo Clinic Proceedings. 2015. March. Vol. 90. № 3. Pp. 372–381 // doi.org/10.1016/j.mayocp.2014.12.019.
Stirpe F. et al. Fructose-induced Hyperuricaemia // The Lancet. 1970. December. Vol. 296. № 7686. Pp. 1310–1311 // doi.org/10.1016/s0140-6736(70)92269-5.
Goran M. I. et al. The Obesogenic Effect of High Fructose Exposure During Early Development // Nature Reviews Endocrinology. 2013. August. Vol. 9. № 8. Pp. 494–500.
Rivard Ch. et al. Sack and Sugar, and the Aetiology of Gout in England Between 1650 and 1900 // Rheumatology. 2013. March. Vol. 52. № 3. Pp. 421–426 // doi.org/10.1093/rheumatology/kes297.
Zgaga L. et al. The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study // PLOS ONE. 2012. Vol. 7. № 6. P. e38123 // doi.org/10.1371/journal.pone.0038123.
Singh J. A., Reddy S. G., Kundukulam J. Risk Factors for Gout and Prevention: A Systematic Review of the Literature // Current Opinion in Rheumatology. 2011. March. Vol. 23. № 2. Pp. 192–202 // doi.org/10.1097/BOR.0b013e3283438e13.
LUV созвучно английскому слову love (любовь). Прим. пер.
Выражение автора, означающее, что мочевая кислота разрушает организм, как бомба. Прим. пер.
Enzinger Ch. et al. Risk Factors for Progression of Brain Atrophy in Aging: Six-Year Follow-Up of Normal Subjects // Neurology. 2005. May 24. Vol. 64. № 10. Pp. 1704–1711 // doi.org/10.1212/01.WNL.0000161871.83614.BB.
Crane P. K. et al. Glucose Levels and Risk of Dementia // New England Journal of Medicine. 2013. August. Vol. 369. № 6. Pp. 540–548 // doi.org/10.1056/NEJMoa1215740.
Van Pelt G. W. A Study of Haig’s Uric Acid Theory // Boston Medical and Surgical Journal. 1896. Vol. 134. № 6. Pp. 129–134 // doi.org/10.1056/NEJM189602061340601.
Johnson R. J. et al. Lessons from Comparative Physiology: Could Uric Acid Represent a Physiologic Alarm Signal Gone Awry in Western Society? // Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology. 2009. January. Vol. 179. № 1. Pp. 67–76 // doi.org/10.1007/s00360-008-0291-7.
Framingham Heart Study // framinghamheartstudy.org.
Culleton B. F. et al. Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study // Annals of Internal Medicine. 1999. July. Vol. 131. № 1. Pp. 7–13 // doi.org/10.7326/0003-4819-131-1-199907060-00003.
Неполный список исследовательских работ доктора Ричарда Джонсона есть на его странице scholar.google.com/citations?user=dTgECeMAAAAJ&hl=en.
Johnson R. J., Andrews P. The Fat Gene // Scientific American. 2015. October. Vol. 313. № 4. Pp. 64–69 // doi.org/10.1038/scientificamerican1015-64.
Johnson and Andrews. The Fat Gene.
Johnson and Andrews. The Fat Gene.
Feig D. I., Soletsky B., Johnson R. J. Effect of Allopurinol on Blood Pressure of Adolescents with Newly Diagnosed Essential Hypertension: A Randomized Trial // JAMA. 2008. August. Vol. 300. № 8. Pp. 924–932 // doi.org/10.1001/jama.300.8.924.
Kanbay M. et al. A Randomized Study of Allopurinol on Endothelial Function and Estimated Glomular Filtration Rate in Asymptomatic Hyperuricemic Subjects with Normal Renal Function // Clinical Journal of the American Society of Nephrology. 2011. August. Vol. 6. № 8. Pp. 1887–1894 // doi.org/10.2215/CJN.11451210. См. также George J., Struthers A. D. Role of Urate, Xanthine Oxidase and the Effects of Allopurinol in Vascular Oxidative Stress // Vascular Health and Risk Management. 2009. Vol. 5. № 1. Pp. 265–272 // doi.org/10.2147/vhrm.s4265; Muir S. W. et al. Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those with Recent Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial // Stroke. 2008. December. Vol. 39. № 12. Pp. 3303–3307 // doi.org/10.1161/STROKEAHA.108.519793; Dawson J. et al. The Effect of Allopurinol on the Cerebral Vasculature of Patients with Subcortical Stroke; a Randomized Trial // British Journal of Clinical Pharmacology. 2009. November. Vol. 68. № 5. Pp. 662–668 // doi.org/10.1111/j.1365–2125.2009.03497.x; García-Arroyo F. E. et al. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats // Biomolecules. 2019. October. Vol. 9. № 10. P. 601 // doi.org/10.3390/biom9100601; Singh J. A., Yu Sh. Allopurinol and the Risk of Stroke in Older Adults Receiving Medicare // BMC Neurology. 2016. September. Vol. 16. № 1. P. 164 // doi.org/10.1186/s12883-016-0692-2; Bove M. et al. An Evidence-Based Review on Urate-Lowering Treatments: Implications for Optimal Treatment of Chronic Hyperuricemia // Vascular Health and Risk Management. 2017. February. Vol. 13. Pp. 23–28 // doi.org/10.2147/VHRM.S115080.
Piani F., Cicero A. F. G., Borghi C. Uric Acid and Hypertension: Prognostic Role and Guide for Treatment // Journal of Clinical Medicine. 2021. January. Vol. 10. № 3. P. 448 // doi.org/10.3390/jcm10030448. См. также Xiong Q., Liu J., Xu Y. Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications // International Journal of Endocrinology. 2019. October. Article ID 9691345 // doi.org/10.1155/2019/9691345; Gill A. et al. Correlation of the Serum Insulin and the Serum Uric Acid Levels with the Glycated Haemoglobin Levels in the Patients of Type 2 Diabetes Mellitus // Journal of Clinical and Diagnostic Research. 2013. July. Vol. 7. № 7. Pp. 1295–1297 // doi.org/10.7860/JCDR/2013/6017.3121; Soltani Z. et al. Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal? // Current Hypertension Reports. 2013. June. Vol. 15. № 3. Pp. 175–181 // doi.org/10.1007/s11906-013-0344-5; Madero M. et al. A Pilot Study on the Impact of a Low Fructose Diet and Allopurinol on Clinic Blood Pressure Among Overweight and Prehypertensive Subjects: A Randomized Placebo Controlled Trial // Journal of the American Society of Hypertension. 2015. November. Vol. 9. № 11. Pp. 837–844 // doi.org/10.1016/j.jash.2015.07.008.
Kratzer J. T. et al. Evolutionary History and Metabolic Insights of Ancient Mammalian Uricases // Proceedings of the National Academy of Sciences (USA). 2014. March. Vol. 111. № 10. Pp. 3763–3768 // doi.org/10.1073/pnas.1320393111.
Rendeiro C. et al. Fructose Decreases Physical Activity and Increases Body Fat Without Affecting Hippocampal Neurogenesis and Learning Relative to an Isocaloric Glucose Diet // Scientific Reports. 2015. Vol. 5. P. 9589 // doi.org/10.1038/srep09589. См. также Beckman Institute for Advanced Science and Technology. Fructose Contributes to Weight Gain, Physical Inactivity, and Body Fat, Researchers Find // ScienceDaily, June 1, 2015 // sciencedaily.com/releases/2015/06/150601122540.htm.
Figlewicz D. P. et al. Effect of Moderate Intake of Sweeteners on Metabolic Health in the Rat // Physiology & Behavior. 2009. December. Vol. 98. № 5. Pp. 618–624 // doi.org/10.1016/j.physbeh.2009.09.016. См. также Aeberli I. et al. Moderate Amounts of Fructose Consumption Impair Insulin Sensitivity in Healthy Young Men: A Randomized Controlled Trial // Diabetes Care. 2013. January. Vol. 36. № 1. Pp. 150–156 // doi.org/10.2337/dc12-0540.
Kanbay M. et al. Uric Acid in Metabolic Syndrome: From an Innocent Bystander to a Central Player // European Journal of Internal Medicine. 2016. April. Vol. 29. Pp. 3–8 // doi.org/10.1016/j.ejim.2015.11.026.
Konta T. et al. Association Between Serum Uric Acid Levels and Mortality: A Nationwide Community-Based Cohort Study // Scientific Reports. 2020. April. Vol. 10. № 1. P. 6066 // doi.org/10.1038/s41598-020-63134-0.
Chen J.-H. et al. Serum Uric Acid Level as an Independent Risk Factor for All-Cause, Cardiovascular, and Ischemic Stroke Mortality: A Chinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol. 61. № 2. Pp. 225–232 // doi.org/10.1002/art.24164.
Zhao Y.-C. et al. Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension // Hypertension. 2020. February. Vol. 75. № 2. Pp. 275–284 // doi.org/10.1161/HYPERTENSIONAHA.119.13419. См. также Kasper P. et al. NAFLD and Cardiovascular Diseases: A Clinical Review // Clinical Research in Cardiology. 2021. July. Vol. 110. № 7. Pp. 921–937 // doi.org/10.1007/s00392-020-01709-7.
Younossi Z. M. Non-alcoholic Fatty Liver Disease – A Global Public Health Perspective // Journal of Hepatology. 2019. March. Vol. 70. № 3. Pp. 531–544 // doi.org/10.1016/j.jhep.2018.10.033.
Darmawan G., Hamijoyo L., Hasan I. Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease: A Meta-Analysis // Acta Medica Indonesiana. 2017. April. Vol. 49. № 2. Pp. 136–147. См. также Margariti E. et al. Non-alcoholic Fatty Liver Disease May Develop in Individuals with Normal Body Mass Index // Annals of Gastroenterology. 2012. Vol. 25. № 1. Pp. 45–51; Oral A. et al. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-obese Patients // Medicina. 2019. September. Vol. 55. № 9. P. 600 // doi.org/10.3390/medicina55090600.
Paschos P. et al. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? // Current Vascular Pharmacology. 2018. Vol. 16. № 3. Pp. 269–275 // doi.org/10.2174/1570161115666170621082237.
Spiga R. et al. Uric Acid Is Associated with Inflammatory Biomarkers and Induces Inflammation via Activating the NF-κB Signaling Pathway in HepG2 Cells // Arteriosclerosis, Thrombosis, and Vascular Biology. 2017. June. Vol. 37. № 6. Pp. 1241–1249 // doi.org/10.1161/ATVBAHA.117.309128. См. также Tanaka T. et al. A Double Blind Placebo Controlled Randomized Trial of the Effect of Acute Uric Acid Changes on Inflammatory Markers in Humans: A Pilot Study // PLOS ONE. 2017. August. Vol. 12. № 8. P. e0181100 // doi.org/10.1371/journal.pone.0181100; Ruggiero C. et al. Uric Acid and Inflammatory Markers // European Heart Journal. 2006. May. Vol. 27. № 10. Pp. 1174–1181 // doi.org/10.1093/eurheartj/ehi879.
Gorman Ch., Park A., Dell K. Health: The Fires Within // Time. 2004. February 23. Vol. 163. № 8.
Gorman, Park, Dell. Health.
Gorman, Park, Dell. Health.
См. запись моего подкаста с доктором Людвигом от 3 января 2016 г. на Drperlmutter.com. Больше о докторе Людвиге и его работе см. Drdavidludwig.com.